Cite
HARVARD Citation
Schenker, H. et al. (n.d.). THU0105 Prediction of response to CERTOLIZUMAB-PEGOL in rheumatoid arthritis (PRECEPRA) by functional MRI of the brain – an interim analysis of an ongoing investigator initiated phase III trial. Annals of the rheumatic diseases. p. 240. [Online].